An observational study in Fetal Hemoglobin, sponsored by The First Hospital of Jilin University. Status unknown at 1 site in China. Open to participants aged 1 Day to 2 Months. Per ClinicalTrials.gov, last updated 2023-03-29.
Sponsored by The First Hospital of Jilin University · Observational
A monocentric prospective study was conducted to find the relevance between the level of fetal hemoglobin and short-term complications in extremely preterm infants
The First Hospital of Jilin University is the lead sponsor of 181 studies on the registry; 93 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Preterm infants with gestational age \<32 weeks or birth weight \<1500g
Exclusion Criteria:
Incorporate blood gas analysis indicators in D1-D7, after birth,1 week before and on the day of onset of early complications
Incorporate blood gas analysis indicators in D1-D7,D14,D28after birth and the day of diacharge
Occurrence and severity of early complications in premature infants
include necrotizing enterocolitis,bronchopulmonary dysplasia,retinopathy, Intraventricular hemorrhage above degree Ⅱ,leukomalacia,late-onset sepsis
Time frame: 2022.1-2023.1
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The First Hospital of Jilin University